MALIGNANT MESOTHELIOMA
Clinical trials for MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called ISM6331 in people with advanced mesothelioma or other solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 100 adults w…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
Experimental therapy uses patients' own lung fluid cells to attack cancer
Disease control Recruiting nowThis early-phase study tests a new immunotherapy called Fast TIL for people with cancer that has spread to the pleura (the lining around the lungs) or pleural mesothelioma. Researchers take immune cells from the patient's own pleural fluid, grow them in the lab, and return them t…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: David Bartlett, MD • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope for mesothelioma patients: targeted drug aims to stop tumor growth
Disease control Recruiting nowThis study tests a drug called Adcetris (brentuximab vedotin) in people with a rare cancer called CD30+ malignant mesothelioma that cannot be removed by surgery. The drug is a type of antibody that targets a protein (CD30) on cancer cells to stop them from growing. About 55 adult…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Your own immune cells could fight lung lining cancer in new trial
Disease control Recruiting nowThis early-phase study tests a new treatment called Fast TIL for people with cancer that has spread to the lining around the lungs (pleura) or mesothelioma. The treatment uses immune cells taken from the patient's own pleural fluid, grown in a lab, and then given back through a c…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC